Table 3.
Correlations between EAITQ or EWITQ Scores and patient characteristics and patient-reported outcomes at baseline and end-point
Correlation with EAITQ score | Correlation with EWITQ score | |
---|---|---|
EAITQ score | – | 0.33* |
Age | −0.11 | −0.11 |
Diabetes duration | −0.08 | −0.20* |
Body mass index | 0.04 | −0.10 |
Baseline | End-point | |
A1c | 0.04 | 0.03 |
DTSQs subscales | ||
Diabetes treatmentsatisfaction | 0.11 | 0.53* |
Perceived hyperglycaemia† | 0.09 | −0.23* |
Perceived hypoglycaemia† | −0.10 | −0.13 |
DSC-R subscales | ||
Hypoglycaemia† | −0.04 | −0.13 |
Hyperglyacemia† | 0.05 | −0.07 |
Psychological† | −0.04 | −0.20* |
W-BQ subscales | ||
Negative well-being† | −0.13 | −0.17* |
Energy | 0.17 | 0.30* |
Positive well-being | 0.14 | 0.42* |
EAITQ/EWITQ self-efficacy | 0.46* | 0.56* |
p < 0.01;
lower scores represent less perceived hyperglycaemia or hypoglycaemia, negative well-being, or symptom burden. DSC-R, diabetes symptoms checklist-revised; DTSQ, Diabetes Treatment Satisfaction Questionnaire Status Version; EAITQ, Expectations About Insulin Therapy; EWITQ, Experience With Insulin Therapy Questionnaires; W-BQ, Well-Being Questionnaire.